SCHEMBL7146568

SCHEMBL7146568

COc1c(C(N)=O)cc(-c2cccc(Cl)c2)n2n[c]nc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 3/20 0.38
PARP1 P09874 1/20 0.38
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
TUBB4A P04350 2/20 0.37
TUBB P07437 2/20 0.37
TUBA3C P0DPH7 2/20 0.37
TUBA1B P68363 2/20 0.37
TUBA4A P68366 2/20 0.37
TUBB4B P68371 2/20 0.37
TUBB3 Q13509 2/20 0.37
TUBB2A Q13885 2/20 0.37
TUBB8 Q3ZCM7 2/20 0.37
TUBA3E Q6PEY2 2/20 0.37
TUBA1A Q71U36 2/20 0.37
TUBA1C Q9BQE3 2/20 0.37
TUBB6 Q9BUF5 2/20 0.37
TUBB2B Q9BVA1 2/20 0.37
TUBB1 Q9H4B7 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7043840 0.89 PARP1 (0.43) IKBKBPARP1KDM4ESLC9A1MAPT
SCHEMBL7145673 0.89 TLR8 (0.48) IKBKBPARP1TUBB4ATUBBTUBA3C
SCHEMBL7041861 0.89 IKBKB (0.46) IKBKBKMT2AKDM4EMEN1TLR8
SCHEMBL6876511 0.88 FYN (0.37) IKBKBTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL7146891 0.88 NTRK1 (0.41) IKBKBKMT2AKDM4EMEN1TUBB4A
SCHEMBL7146854 0.87 PDE4D (0.43) IKBKBFYN
SCHEMBL7150015 0.85 KDM4E (0.49) PARP1KDM4ESLC9A1FYNJAK2
SCHEMBL7041042 0.85 HPGD (0.39) KDM4EMAPTFYNSMN1; SMN2
SCHEMBL7144539 0.85 FYN (0.46) PARP1FYN
SCHEMBL7144535 0.83 NTRK1 (0.40) IKBKBPARP1TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed